Literature DB >> 20534532

Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.

Balaji Manicassamy1, Santhakumar Manicassamy, Alan Belicha-Villanueva, Giuseppe Pisanelli, Bali Pulendran, Adolfo García-Sastre.   

Abstract

Influenza A virus is being extensively studied because of its major impact on human and animal health. However, the dynamics of influenza virus infection and the cell types infected in vivo are poorly understood. These characteristics are challenging to determine, partly because there is no efficient replication-competent virus expressing an easily traceable reporter gene. Here, we report the generation of a recombinant influenza virus carrying a GFP reporter gene in the NS segment (NS1-GFP virus). Although attenuated when compared with wild-type virus, the NS1-GFP virus replicates efficiently in murine lungs and shows pathogenicity in mice. Using whole-organ imaging and flow cytometry, we have tracked the dynamics of influenza virus infection progression in mice. Imaging of murine lungs shows that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs. In addition to epithelial cells, we found GFP-positive antigen-presenting cells, such as CD11b(+)CD11c(-), CD11b(-)CD11c(+), and CD11b(+)CD11c(+), as early as 24 h after intranasal infection. In addition, a significant proportion of NK and B cells were GFP positive, suggesting active infection of these cells. We next tested the effects of the influenza virus inhibitors oseltamivir and amantadine on the kinetics of in vivo infection progression. Treatment with oseltamivir dramatically reduced influenza infection in all cell types, whereas, surprisingly, amantadine treatment more efficiently blocked infection in B and NK cells. Our results demonstrate high levels of immune cells harboring influenza virus antigen during viral infection and cell-type-specific effects upon treatment with antiviral agents, opening additional avenues of research in the influenza virus field.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534532      PMCID: PMC2895123          DOI: 10.1073/pnas.0914994107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

Authors:  Roi Gazit; Raizy Gruda; Moran Elboim; Tal I Arnon; Gil Katz; Hagit Achdout; Jacob Hanna; Udi Qimron; Guy Landau; Evgenia Greenbaum; Zichria Zakay-Rones; Angel Porgador; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

2.  Differential response of respiratory dendritic cell subsets to influenza virus infection.

Authors:  Xueli Hao; Taeg S Kim; Thomas J Braciale
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

3.  Structure and mechanism of the M2 proton channel of influenza A virus.

Authors:  Jason R Schnell; James J Chou
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

4.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Authors:  Anthony E Fiore; David K Shay; Karen Broder; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy S Cox
Journal:  MMWR Recomm Rep       Date:  2008-08-08

Review 5.  Antiviral drugs for the control of pandemic influenza virus.

Authors:  Richard J Sugrue; Boon Huan Tan; Dawn S Y Yeo; Richard Sutejo
Journal:  Ann Acad Med Singap       Date:  2008-06       Impact factor: 2.473

6.  Multiple anti-interferon actions of the influenza A virus NS1 protein.

Authors:  Georg Kochs; Adolfo García-Sastre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

7.  Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures.

Authors:  Andrew Pekosz; Celeste Newby; Pulkit S Bose; Andrew Lutz
Journal:  Virology       Date:  2009-02-04       Impact factor: 3.616

8.  H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.

Authors:  Lucy A Perrone; Julie K Plowden; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey
Journal:  PLoS Pathog       Date:  2008-08-01       Impact factor: 6.823

9.  Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses.

Authors:  Taeg S Kim; Thomas J Braciale
Journal:  PLoS One       Date:  2009-01-15       Impact factor: 3.240

Review 10.  Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses.

Authors:  M A Billeter; H Y Naim; S A Udem
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

View more
  234 in total

Review 1.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

2.  Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.

Authors:  Sergiy V Avilov; Dorothée Moisy; Sandie Munier; Oliver Schraidt; Nadia Naffakh; Stephen Cusack
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 4.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

5.  Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Authors:  Markus Wolschek; Elisabeth Samm; Helena Seper; Sanda Sturlan; Irina Kuznetsova; Cornelia Schwager; Alexandra Khassidov; Christian Kittel; Thomas Muster; Andrej Egorov; Michael Bergmann
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

7.  DDX3 Interacts with Influenza A Virus NS1 and NP Proteins and Exerts Antiviral Function through Regulation of Stress Granule Formation.

Authors:  Sathya N Thulasi Raman; Guanqun Liu; Hyun Mi Pyo; Ya Cheng Cui; Fang Xu; Lisanework E Ayalew; Suresh K Tikoo; Yan Zhou
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

Review 8.  Protective B cell responses to flu--no fluke!

Authors:  Elizabeth E Waffarn; Nicole Baumgarth
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

9.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

10.  Development of a reverse genetic system for infectious salmon anemia virus: rescue of recombinant fluorescent virus by using salmon internal transcribed spacer region 1 as a novel promoter.

Authors:  Daniela Toro-Ascuy; Carolina Tambley; Carolina Beltran; Carolina Mascayano; Nicolas Sandoval; Eduardo Olivares; Rafael A Medina; Eugenio Spencer; Marcelo Cortez-San Martín
Journal:  Appl Environ Microbiol       Date:  2015-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.